Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation
- 1 May 1997
- journal article
- case report
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (5) , 1148-1153
- https://doi.org/10.1016/s0168-8278(97)80125-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of Hepatitis B Virus Dna Polymerase by Enantiomers of Penciclovir Triphosphate and Metabolic Basis for Selective Inhibition of Hbv Replication by PenciclovirHepatology, 1996
- Penciclovir-Resistance Mutations in the Herpes Simplex Virus DNA Polymerase GeneAntiviral Chemistry and Chemotherapy, 1995
- PROSTAGLANDIN E PLUS FAMCICLOVIR—A NEW CONCEPT FOR THE TREATMENT OF SEVERE HEPATITIS B AFTER LIVER TRANSPLANTATION1,2Transplantation, 1994
- In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virusAntimicrobial Agents and Chemotherapy, 1994
- Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovoJournal of Medical Virology, 1994
- Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infectionJournal of Gastroenterology and Hepatology, 1993
- Famciclovir and Penciclovir. The Mode of Action of Famciclovir Including Its Conversion to PenciclovirAntiviral Chemistry and Chemotherapy, 1993
- The Mechanism of Inhibition of Hepatitis B Virus Replication by the Carbocyclic Analog of 2′–DeoxyguanosineHepatology, 1992
- An attempt to unify the structure of polymerasesProtein Engineering, Design and Selection, 1990
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982